TCIM
PVLA

TIAA CREF Investment Management’s Palvella Therapeutics PVLA Stock Holding History

TIAA CREF Investment Management’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1.11M Buy
4,143
+576
+16% +$137K ﹤0.01% 2272
2018
Q4 		$759K Sell
3,567
-609
-15% -$189K ﹤0.01% 2392
2018
Q3 		$1.87M Buy
4,176
+654
+19% +$284K ﹤0.01% 2148
2018
Q2 		$1.43M Sell
3,522
-1,877
-35% -$893K ﹤0.01% 2335
2018
Q1 		$2.95M Buy
5,399
+1,995
+59% +$1.23M ﹤0.01% 1884
2017
Q4 		$2.06M Buy
3,404
+684
+25% +$318K ﹤0.01% 2114
2017
Q3 		$1.25M Buy
2,720
+1,118
+70% +$477K ﹤0.01% 2411
2017
Q2 		$649K Buy
+1,602
New +$468K ﹤0.01% 2742

Other funds holding PVLA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

TIAA CREF Investment Management's PVLA Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Palvella Therapeutics (PVLA) stake by 16% in Q1 2019, buying an estimated $137K and bringing the position to 4,143 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2272.

TIAA CREF Investment Management first reported a position in PVLA in Q2 2017 and has held it in 8 quarters since. The position peaked at $2.95M in Q1 2018. 92 funds tracked by Wall St. Rank hold PVLA as of Q1 2019.

  • TIAA CREF Investment Management held 4,143 shares of Palvella Therapeutics worth $1.11M as of Q1 2019.
  • TIAA CREF Investment Management bought 576 Palvella Therapeutics shares in Q1 2019, an estimated $137K.
  • Palvella Therapeutics made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2272 holding.
  • TIAA CREF Investment Management first reported a position in Palvella Therapeutics in Q2 2017 and has held it in 8 quarters since.
  • TIAA CREF Investment Management's Palvella Therapeutics position peaked at $2.95M in Q1 2018.
  • 92 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.